lilly glp 1 pill Eli Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk FDA grants speedy approval to

What this changes about automation planning Health systems that have already invested in centralized, automated dispensing are better positioned to absorb GLP-1 volume because their cost per fill is fundamentally lower

There may be currently ongoing studies, or there may be initial studies that indicate these, but which are not robust enough to prove one way or the other yet

Diabetes Metab Syndr 16(3):102427 Sisson EM (2011) Liraglutide: clinical pharmacology and considerations for therapy

(12, 13) By improving glycemic control, enhancing insulin sensitivity, and reducing adiposity, GLP-1 therapies may decrease bone marrow adipose tissue (BMAT) formation and mitigate the harmful effects of hyperglycemia on bone quality